Virtual ISPOR Asia Pacific Summit 2022 will take place in Korea Standard Time (KST).

Tuesday, 20 September

9:00 – 10:15
Opening Plenary

Value or Volume: Are APAC Regions Transforming into Value-Based Health Care? 

Amid the global COVID-19 outbreak, many countries are trying to provide equitable, good quality, and cost-effective healthcare services. The value-based health care (VBHC), which improves healthcare services by increasing outcomes with lowered costs, has been in the spotlight against the volume-based healthcare delivery system such as fee-for-service payment model. Asia Pacific regions are no exception in this global trend of VBHC and the concept of VBHC is rapidly spreading and various demonstrations (e.g., value-based payment, value-based pricing, or value-based procurement, etc.) are being undertaken and more discussion to adopt this value-based approach is underway. There has been divergent operation of VBHC across Asia Pacific regions such as the VBHC arrangements limited to specific technologies (e.g., pharmaceuticals, medical devices, and diagnostics) or comprehensive healthcare delivery transformation to embrace VBHC throughout the healthcare system. In addition, there are some countries that still focus on volume-based payment rather than value as their main theme in payment model.

This session will address the snapshot of VBHC operation across Asia Pacific regions and discuss about the health policy aligned with VBHC in reimbursement, pricing, and payment model and also opportunity and challenges to implement VBHC to help build sustainable and resilient healthcare systems.

10:30 – 11:30
Educational Symposia

11:45 – 12:45
Issue Panel and Workshop Sessions

13:00 – 13:30
Networking Roundtables

Wednesday, 21 September

9:00 – 10:00
Educational Symposia

10:15 – 11:15
Issue Panel and Workshop Sessions

11:30 – 12:30
Issue Panel and Workshop Sessions

12:45 – 14:00
Closing Plenary

Digital Health Innovations: Improving Patient Outcomes and Equity in the Asia Pacific Region

Innovations in digital health technologies have become increasingly available for patients, providers, and health systems.  There is a raft of technologies that could be considered digital health technologies; for example, apps aimed directly at patients and consumers, apps aimed at patients with the interaction with their clinicians, systems aimed at clinicians for example, decision support systems, and digital tools that can be implemented at a system level, such as electronic medical records.  These technologies offer significant promise for improving patient outcomes and reducing inequities; however, these potential benefits need to be balanced against potential downsides. This session will consider how these innovative technologies can be considered within a Health Technology Assessment framework, or other evaluation frameworks to measure how they improve patient health outcomes and equity.